HSBC Holdings’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $313M | Buy |
5,409,898
+588,390
| +12% | +$33.8M | 0.13% | 132 |
|
|
2026
Q1 | $292M | Sell |
4,821,508
-1,603,207
| -25% | -$93.5M | 0.15% | 120 |
|
|
2025
Q4 | $347M | Buy |
6,424,715
+1,624,430
| +34% | +$78.1M | 0.18% | 99 |
|
|
2025
Q3 | $217M | Buy |
4,800,285
+105,768
| +2% | +$4.94M | 0.12% | 160 |
|
|
2025
Q2 | $218M | Buy |
4,694,517
+255,400
| +6% | +$12.5M | 0.13% | 144 |
|
|
2025
Q1 | $270M | Sell |
4,439,117
-165,359
| -4% | -$9.64M | 0.17% | 112 |
|
|
2024
Q4 | $260M | Buy |
4,604,476
+10,176
| +0.2% | +$569K | 0.15% | 114 |
|
|
2024
Q3 | $237M | Sell |
4,594,300
-327,078
| -7% | -$15.3M | 0.14% | 127 |
|
|
2024
Q2 | $205M | Sell |
4,921,378
-488,592
| -9% | -$21.9M | 0.13% | 143 |
|
|
2024
Q1 | $293M | Buy |
5,409,970
+837,307
| +18% | +$42.7M | 0.2% | 89 |
|
|
2023
Q4 | $234M | Buy |
4,572,663
+267,168
| +6% | +$14M | 0.2% | 86 |
|
|
2023
Q3 | $250M | Buy |
4,305,495
+28,613
| +0.7% | +$1.75M | 0.26% | 65 |
|
|
2023
Q2 | $274M | Sell |
4,276,882
-267,106
| -6% | -$17.9M | 0.28% | 62 |
|
|
2023
Q1 | $315M | Buy |
4,543,988
+341,446
| +8% | +$24.1M | 0.38% | 46 |
|
|
2022
Q4 | $302M | Buy |
4,202,542
+1,610,674
| +62% | +$121M | 0.35% | 49 |
|
|
2022
Q3 | $185M | Sell |
2,591,868
-16,972
| -0.7% | -$1.23M | 0.3% | 53 |
|
|
2022
Q2 | $202M | Sell |
2,608,840
-1,786,999
| -41% | -$136M | 0.28% | 58 |
|
|
2022
Q1 | $322M | Sell |
4,395,839
-107,588
| -2% | -$7.22M | 0.39% | 41 |
|
|
2021
Q4 | $282M | Sell |
4,503,427
-359,723
| -7% | -$21.1M | 0.26% | 60 |
|
|
2021
Q3 | $290M | Sell |
4,863,150
-95,311
| -2% | -$6.28M | 0.29% | 55 |
|
|
2021
Q2 | $332M | Sell |
4,958,461
-315,674
| -6% | -$20.6M | 0.35% | 46 |
|
|
2021
Q1 | $334M | Sell |
5,274,135
-1,629,414
| -24% | -$101M | 0.39% | 47 |
|
|
2020
Q4 | $425M | Buy |
6,903,549
+3,883,878
| +129% | +$239M | 0.57% | 24 |
|
|
2020
Q3 | $182M | Sell |
3,019,671
-226,998
| -7% | -$13.7M | 0.29% | 59 |
|
|
2020
Q2 | $191M | Buy |
3,246,669
+227,272
| +8% | +$13.6M | 0.36% | 45 |
|
|
2020
Q1 | $167M | Buy |
3,019,397
+672,496
| +29% | +$41.1M | 0.39% | 42 |
|
|
2019
Q4 | $150M | Buy |
2,346,901
+243,325
| +12% | +$13.9M | 0.26% | 66 |
|
|
2019
Q3 | $107M | Sell |
2,103,576
-247,011
| -11% | -$11.6M | 0.2% | 93 |
|
|
2019
Q2 | $107M | Buy |
2,350,587
+114,896
| +5% | +$5.35M | 0.2% | 100 |
|
|
2019
Q1 | $107M | Sell |
2,235,691
-349,617
| -14% | -$17.4M | 0.19% | 110 |
|
|
2018
Q4 | $134M | Sell |
2,585,308
-964,553
| -27% | -$51.8M | 0.25% | 73 |
|
|
2018
Q3 | $220M | Sell |
3,549,861
-307,179
| -8% | -$18.2M | 0.35% | 49 |
|
|
2018
Q2 | $213M | Sell |
3,857,040
-1,325,761
| -26% | -$71.6M | 0.38% | 41 |
|
|
2018
Q1 | $328M | Buy |
5,182,801
+1,594,739
| +44% | +$103M | 0.49% | 30 |
|
|
2017
Q4 | $220M | Buy |
3,588,062
+820,209
| +30% | +$51.3M | 0.32% | 65 |
|
|
2017
Q3 | $176M | Buy |
2,767,853
+100,962
| +4% | +$5.9M | 0.28% | 65 |
|
|
2017
Q2 | $149M | Buy |
2,666,891
+669,067
| +33% | +$36.4M | 0.27% | 64 |
|
|
2017
Q1 | $109M | Sell |
1,997,824
-740,910
| -27% | -$40.6M | 0.23% | 79 |
|
|
2016
Q4 | $160M | Buy |
2,738,734
+357,136
| +15% | +$19.5M | 0.37% | 47 |
|
|
2016
Q3 | $128M | Sell |
2,381,598
-314,670
| -12% | -$20.2M | 0.32% | 61 |
|
|
2016
Q2 | $198M | Sell |
2,696,268
-137,254
| -5% | -$9.7M | 0.55% | 26 |
|
|
2016
Q1 | $181M | Sell |
2,833,522
-222,394
| -7% | -$14M | 0.51% | 35 |
|
|
2015
Q4 | $210M | Sell |
3,055,916
-391,991
| -11% | -$25.9M | 0.51% | 33 |
|
|
2015
Q3 | $204M | Buy |
3,447,907
+1,023,612
| +42% | +$64.9M | 0.51% | 36 |
|
|
2015
Q2 | $161M | Sell |
2,424,295
-624,737
| -20% | -$41.2M | 0.33% | 61 |
|
|
2015
Q1 | $197M | Sell |
3,049,032
-230,412
| -7% | -$14.4M | 0.38% | 51 |
|
|
2014
Q4 | $194M | Sell |
3,279,444
-3,187,987
| -49% | -$180M | 0.4% | 48 |
|
|
2014
Q3 | $331M | Sell |
6,467,431
-523,435
| -7% | -$26.1M | 0.69% | 25 |
|
|
2014
Q2 | $339M | Buy |
6,990,866
+1,048,891
| +18% | +$51.7M | 0.73% | 22 |
|
|
2014
Q1 | $308M | Buy |
5,941,975
+3,016,990
| +103% | +$161M | 0.74% | 25 |
|
|
2013
Q4 | $156M | Sell |
2,924,985
-490,066
| -14% | -$25M | 0.4% | 43 |
|
|
2013
Q3 | $158M | Buy |
3,415,051
+111,563
| +3% | +$4.9M | 0.43% | 43 |
|
|
2013
Q2 | $148M | Buy |
+3,303,488
| New | +$143M | 0.45% | 45 |
|
Other funds holding BMY
HSBC Holdings's BMY Position: Q2 2026 in Review
HSBC Holdings increased its Bristol-Myers Squibb (BMY) stake by 12% in Q2 2026, buying an estimated $33.8M and bringing the position to 5,409,898 shares worth $313M. The position accounts for 0.13% of the portfolio, ranked #132.
HSBC Holdings first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $425M in Q4 2020. 2,514 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- HSBC Holdings held 5,409,898 shares of Bristol-Myers Squibb worth $313M as of Q2 2026.
- HSBC Holdings bought 588,390 Bristol-Myers Squibb shares in Q2 2026, an estimated $33.8M.
- Bristol-Myers Squibb made up 0.13% of HSBC Holdings's portfolio in Q2 2026, its #132 holding.
- HSBC Holdings first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
- HSBC Holdings's Bristol-Myers Squibb position peaked at $425M in Q4 2020.
- 2,514 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.